|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/14 | (2006.01) |
| C07D 498/14 | (2013.01) | ||
| C07D 513/14 | (2006.01) | ||
| C07D 513/14 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61K 31/553 | (2006.01) | ||
| A61K 31/554 | (2006.01) |
| (11) | Number of the document | 3672975 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18765254.0 |
| Date of filing the European patent application | 2018-08-22 | |
| (97) | Date of publication of the European application | 2020-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/047411 |
| Date | 2018-08-22 |
| (87) | Number | WO 2019/040550 |
| Date | 2019-02-28 |
| (30) | Number | Date | Country code |
| 201762549081 P | 2017-08-23 | US | |
| 201862615007 P | 2018-01-09 | US |
| (72) |
CHEN, Yi , US
LOU, Yan , US
|
| (73) |
Guangzhou Lupeng Pharmaceutical Company Ltd. ,
Room 322, Building B
Shilian Science Park
No. 33 Science Avenue
Huangpu District, Guangzhou City, GuangDong Province,
CN
|
| (54) | CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES |